These results suggest that modulating the level of Bcl-xL Ser14 phosphorylation and downstream mechanisms, including the interaction between Bcl-xL and IP3R, could be a promising intervention against heart failure during acute pressure overload. This evidence concerns the gene BCL2L1 and heart failure.